Nectar Lifesciences Limited has announced the successful completion of its buyback program, during which 3,00,00,000 (Three Crore) equity shares were repurchased at a price of ₹27 per share. The settlement for these buyback transactions was finalized on January 13, 2026. The company is currently in the process of extinguishing these repurchased shares.

This announcement follows up on previous disclosures regarding the dispatch of the Letter of Offer for the buyback, which commenced on December 31, 2025, and concluded on January 06, 2026. The company has published a Post Buyback Public Announcement on January 15, 2026, in leading newspapers including Business Standard (English and Hindi, all editions) and Desh Sewak (Punjab editions).